HKI6MAG-99K
MILLIPLEX® Human Kidney Injury Panel
Configurable Human Kidney Toxicity 4-plex Panel 6
この商品について
製品名
MILLIPLEX® Human Kidney Injury Panel,
Quality Level
description
Configurable Human Kidney Toxicity 4-plex Panel 6
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
accuracy: 103-133%, intra-assay cv: <10, sensitivity: 0.10-3.42 ng/mL
(MinDC+2SD), standard curve range: 0.05-50 ng/mL
(β-2-Microglobulin (β2M)), standard curve range: 0.10-100 ng/mL
(RBP4), standard curve range: 0.59-600 ng/mL
(Cystatin C), standard curve range: 2.93-3,000 ng/mL
(Clusterin)
technique(s)
multiplexing: suitable
input
plasma
serum
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: β-2-Microglobulin, Clusterin, Cystatin C, Retinol Binding Protein 4 (RBP4)
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Multiplex capability for simultaneous detection of 4 analytes
- Magnetic bead-based format compatible with Luminex® xMAP® technology
- Verified biomarkers: β-2-Microglobulin, Clusterin, Cystatin C, Retinol Binding Protein 4 (RBP4)
- Optimized for use with human serum and plasma samples
- Includes all necessary reagents, standards, and controls
- Designed for overnight incubation for enhanced sensitivity
- Conserves sample volume and reduces assay time
- Improves reproducibility and throughput with magnetic bead handling
- Enables comprehensive profiling of kidney injury biomarkers
- Supports toxicology and nephrology research applications
- Streamlines workflow with ready-to-use components
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
保管分類
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
関連コンテンツ
Exploring genotoxicity and DNA damage through multiplexing with MILLIPLEX® multiplex genotoxicity assays using Luminex® xMAP® technology enables the high-throughput measurement of phosphorylation levels of multiple proteins simultaneously and reduces sample volume, time, and cost.
Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.
Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.